Time-restricted feeding improves adaptation to chronically alternating light-dark cycles.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 05 2019
Historique:
received: 27 10 2017
accepted: 02 05 2019
entrez: 29 5 2019
pubmed: 28 5 2019
medline: 21 10 2020
Statut: epublish

Résumé

Disturbance of the circadian clock has been associated with increased risk of cardio-metabolic disorders. Previous studies showed that optimal timing of food intake can improve metabolic health. We hypothesized that time-restricted feeding could be a strategy to minimize long term adverse metabolic health effects of shift work and jetlag. In this study, we exposed female FVB mice to weekly alternating light-dark cycles (i.e. 12 h shifts) combined with ad libitum feeding, dark phase feeding or feeding at a fixed clock time, in the original dark phase. In contrast to our expectations, long-term disturbance of the circadian clock had only modest effects on metabolic parameters. Mice fed at a fixed time showed a delayed adaptation compared to ad libitum fed animals, in terms of the similarity in 24 h rhythm of core body temperature, in weeks when food was only available in the light phase. This was accompanied by increased plasma triglyceride levels and decreased energy expenditure, indicating a less favorable metabolic state. On the other hand, dark phase feeding accelerated adaptation of core body temperature and activity rhythms, however, did not improve the metabolic state of animals compared to ad libitum feeding. Taken together, restricting food intake to the active dark phase enhanced adaptation to shifts in the light-dark schedule, without significantly affecting metabolic parameters.

Identifiants

pubmed: 31133707
doi: 10.1038/s41598-019-44398-7
pii: 10.1038/s41598-019-44398-7
pmc: PMC6536683
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7874

Références

J Biol Rhythms. 2011 Aug;26(4):324-34
pubmed: 21775291
Methods Enzymol. 2015;552:257-83
pubmed: 25707281
Front Physiol. 2016 Dec 21;7:636
pubmed: 28066267
Eur J Neurosci. 2017 Aug;46(3):1875-1886
pubmed: 28661071
Eur J Public Health. 2019 Feb 1;29(1):128-134
pubmed: 29796606
Genes Dev. 2000 Dec 1;14(23):2950-61
pubmed: 11114885
Sleep. 2004 Dec 15;27(8):1453-62
pubmed: 15683134
Best Pract Res Clin Endocrinol Metab. 2010 Oct;24(5):785-800
pubmed: 21112026
Int J Mol Sci. 2016 Dec 10;17(12):
pubmed: 27973397
FASEB J. 2012 Aug;26(8):3493-502
pubmed: 22593546
Genes Cells. 2014 May;19(5):441-8
pubmed: 24698115
Endocrinology. 2004 Jul;145(7):3258-64
pubmed: 15059949
Obes Rev. 2014 Sep;15(9):709-20
pubmed: 24888416
Physiol Behav. 2014 Apr 10;128:188-201
pubmed: 24534172
Physiol Behav. 2013 Jun 13;118:14-24
pubmed: 23660277
Biochim Biophys Acta. 2013 Jan;1832(1):228-38
pubmed: 22952003
BMJ. 2016 Nov 1;355:i5210
pubmed: 27803010
J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2006 Jul;192(7):701-14
pubmed: 16421752
Physiol Rep. 2016 Apr;4(8):
pubmed: 27125665
Neuroscience. 2013 Sep 17;248:459-68
pubmed: 23811394
PLoS One. 2013;8(4):e60052
pubmed: 23565183
J Nurs Res. 2011 Mar;19(1):68-81
pubmed: 21350389
J Biol Rhythms. 2013 Apr;28(2):130-40
pubmed: 23606612
Diabetes. 2008 Jul;57(7):1790-9
pubmed: 18398139
Curr Biol. 2015 Jul 20;25(14):1932-7
pubmed: 26196479
Obesity (Silver Spring). 2009 Nov;17(11):2100-2
pubmed: 19730426
PLoS One. 2012;7(11):e49993
pubmed: 23166806
Am J Public Health. 2007 Apr;97 Suppl 1:S88-92
pubmed: 17413074
Endocrinology. 2010 Mar;151(3):1019-29
pubmed: 20080873
JAMA. 2016 Apr 26;315(16):1726-34
pubmed: 27115377
J Biol Rhythms. 2011 Oct;26(5):464-7
pubmed: 21921300
Biochem Biophys Res Commun. 2015 Sep 25;465(3):556-61
pubmed: 26297949
Occup Environ Med. 2015 Jan;72(1):72-8
pubmed: 25030030
Saf Health Work. 2010 Dec;1(2):112-23
pubmed: 22953171
Int J Obes (Lond). 2010 Nov;34(11):1589-98
pubmed: 20351731
Infant Behav Dev. 2006 Apr;29(2):143-52
pubmed: 17138270
Curr Opin Oncol. 2015 Jan;27(1):50-6
pubmed: 25405464
Sci Rep. 2016 Oct 20;6:35662
pubmed: 27762290
Biogerontology. 2017 Jun;18(3):321-332
pubmed: 28357524
PLoS One. 2012;7(8):e44053
pubmed: 22952870
Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E212-7
pubmed: 15741238
Front Pharmacol. 2015 Mar 24;6:50
pubmed: 25852554

Auteurs

Maaike Schilperoort (M)

Department of Medicine, Division of Endocrinology & Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Rosa van den Berg (R)

Department of Medicine, Division of Endocrinology & Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Martijn E T Dollé (MET)

Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

Conny T M van Oostrom (CTM)

Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Karina Wagner (K)

Department of Medicine, Division of Endocrinology & Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Lauren L Tambyrajah (LL)

Department of Medicine, Division of Endocrinology & Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Paul Wackers (P)

Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Tom Deboer (T)

Laboratory for Neurophysiology, Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands.

Gerben Hulsegge (G)

Department of Public and Occupational Health, Amsterdam Public Health research institute, Amsterdam, UMC, The Netherlands.

Karin I Proper (KI)

Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Harry van Steeg (H)

Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Till Roenneberg (T)

Institute for Medical Psychology, LMU, Munich, Germany.

Nienke R Biermasz (NR)

Department of Medicine, Division of Endocrinology & Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Patrick C N Rensen (PCN)

Department of Medicine, Division of Endocrinology & Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Sander Kooijman (S)

Department of Medicine, Division of Endocrinology & Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Linda W M van Kerkhof (LWM)

Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Linda.van.kerkhof@rivm.nl.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH